Return to Wellspring Worldwide

Related Groups

Communicate

In vitro human GI model to screen for drug candidates, nutraceuticals, food, etc.

 Learn more about this Project

Details

Project TitleIn vitro human GI model to screen for drug candidates, nutraceuticals, food, etc.
Track CodeP3181
Short DescriptionMcGill University is offering a unique service based on an in vitro human GI tract system. Dr. Satya Prakash’s laboratory is the only laboratory in North America equipped with the Simulator of Human Intestinal Microbial Ecosystem (SHIME) device
AbstractNone
 
TagsNone
 
Posted DateJan 25, 2010 8:34 AM

Additional

  • Journal of Microencapsulation, 2005; 22(5), 539–547
  • Artificial Cells, Blood Substitutes, and Biotechnology, 2007, 35, 359–375
  • Journal of Biomedicine and Biotechnology, 2007, 7, 13684
  • Appl Microbiol Biotechnol., 2008, 81, 225–233

Background

SHIME was developed by ProDigest BVBA in Belgium (see www.prodigest.eu). McGill, Dr. Prakash and ProDigest are working in close collaboration to offer services to the pharmaceutical, biotechnology and food industry.

Advantages

  •  Dynamic model to study physiochemical, enzymatic and microbial parameters in the GI track in controlled in vitro settings;.
  • Model allows studying the entire GI track: stomach, small intestine and colon;
  • Easy way to assess drug candidates, food or nutraceutical products solubility, degradation and absorption;
  • Unique model to study the impact of drug candidates on GI microbial community;
  • Unique model to evaluate efficacy of probiotic/symbiotic treatments;
  • Alternative approach to expensive animal and human studies